Tα1 treatment was associated with higher ΔSOFAday07 in patients with sepsis
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Sample size (n) | 288 | 288 | 222 |
| Tα1 treatment | 0.510 (0.299–0.869) | 0.523 (0.301–0.909) | 0.336 (0.170–0.663) |
Values are ORs (95% CIs) unless stated otherwise. aAdjusted for sex, age, pre-existing condition, initial SOFA score, and baseline mHLA-DR; badjusted for covariates in model 2 after PSM